ConductScience.org, home

Paper21079428

The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study.

Durovni B and 11 others. AIDS, 2010. Cited by 52 papers, by iCite.

Cite this record

ConductScience Library. The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study. Papers, record 21079428. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21079428

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The implementation of isoniazid preventive therapy in HIV clinics: the experience from the TB/HIV in Rio (THRio) study.
PubMed
Journal
AIDS
PubMed
Year
2010
PubMed
Publication types
Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
1.62
iCite
Revised in PubMed
2025-05-29
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Durovni BBetina
2Cavalcante SCSolange C
3Saraceni VValeria
4Vellozo VVitoria
5Israel GGiselle
6King BSBonnie S
7Cohn SSilvia
8Efron AAnne
9Pacheco AGAntonio G
10Moulton LHLawrence H
11Chaisson RERichard E
12Golub JEJonathan E

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antitubercular AgentsMajor topic
Delivery of Health Care, IntegratedMajor topic
HIV InfectionsMajor topic
HIV-1Major topic
IsoniazidMajor topic
TuberculosisMajor topic
Brazil
Female
Humans
Incidence
Male
Viral Load

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K01 AI066994NIAID NIH HHSUnited StatesK01AI066994PubMed and NIHNIH RePORTER
K24 AI001637NIAID NIH HHSUnited StatesK24AI001637PubMed and NIHNIH RePORTER
AI066994NIAID NIH HHSUnited StatesK01AI066994PubMed and NIHNIH RePORTER
AI001637NIAID NIH HHSUnited StatesK24AI001637PubMed and NIHNIH RePORTER

Download CSV of grants

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT03302299Alcohol Drinkers' Exposure to Preventive Therapy for TB (ADEPTT)BackgroundClinicalTrials.gov
NCT03537872PROvide MIner-friendly SErvices for Integrated TB/HIV Care in Lesotho StudyBackgroundClinicalTrials.gov

Download CSV of trials

References16

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117589190The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.AIDS2007https://conductscience.org/library/papers/17589190PubMed
29233868A controlled trial of isoniazid in persons with anergy and human immunodeficiency virus infection who are at high risk for tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS.N Engl J Med1997https://conductscience.org/library/papers/9233868PubMed
311092714HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group.Int J Tuberc Lung Dis2000https://conductscience.org/library/papers/11092714PubMed
418544202Tuberculosis as primary cause of death among AIDS cases in Rio de Janeiro, Brazil.Int J Tuberc Lung Dis2008https://conductscience.org/library/papers/18544202PubMed
59519950Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection.Lancet1998https://conductscience.org/library/papers/9519950PubMed
620091503Treatment of latent tuberculosis infection in HIV infected persons.Cochrane Database Syst Rev2010https://conductscience.org/library/papers/20091503PubMed
79295239A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration.N Engl J Med1997https://conductscience.org/library/papers/9295239PubMed
89875583Twice weekly tuberculosis preventive therapy in HIV infection in Zambia.AIDS1998https://conductscience.org/library/papers/9875583PubMed
911684932Chemoprophylaxis for tuberculosis and survival of HIV-infected patients in Brazil.AIDS2001https://conductscience.org/library/papers/11684932PubMed
1010997404Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infection.AIDS2000https://conductscience.org/library/papers/10997404PubMed
1112742798The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.Arch Intern Med2003https://conductscience.org/library/papers/12742798PubMed
1218781195AIDS-related tuberculosis in Rio de Janeiro, Brazil.PLoS One2008https://conductscience.org/library/papers/18781195PubMed
1312086758Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study.Lancet2002https://conductscience.org/library/papers/12086758PubMed
1417456522Statistical design of THRio: a phased implementation clinic-randomized study of a tuberculosis preventive therapy intervention.Clin Trials2007https://conductscience.org/library/papers/17456522PubMed
1511797184Reduced risk of tuberculosis among Brazilian patients with advanced human immunodeficiency virus infection treated with highly active antiretroviral therapy.Clin Infect Dis2002https://conductscience.org/library/papers/11797184PubMed
168101302Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection.Lancet1993https://conductscience.org/library/papers/8101302PubMed

Download CSV of references

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
41666121
Acceptability and safety of one versus three months of rifapentine and isoniazid to prevent tuberculosis in people exposed in the household or workplace in Brazil: The Ultra-Curto randomized controlled trial.
PLoS Med2026https://conductscience.org/library/papers/41666121PubMed
39453876Sex differences in tuberculosis infection and disease among people with HIV.AIDS2025https://conductscience.org/library/papers/39453876PubMed
38356778A validated liquid chromatography-tandem mass spectrometry assay for the analysis of isoniazid and its metabolite acetyl-isoniazid in urine.J Mass Spectrom Adv Clin Lab2024https://conductscience.org/library/papers/38356778PubMed
36229905Knowledge and Attitudes of Indonesian General Practitioners Towards the Isoniazid Preventive Therapy Program in Indonesia.J Prev Med Public Health2022https://conductscience.org/library/papers/36229905PubMed
35927793Drop-offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015-2019.J Int AIDS Soc2022https://conductscience.org/library/papers/35927793PubMed
35899273Isoniazid Adherence Reduces Mortality and Incident Tuberculosis at 96 Weeks Among Adults Initiating Antiretroviral Therapy With Advanced Human Immunodeficiency Virus in Multiple High-Burden Settings.Open Forum Infect Dis2022https://conductscience.org/library/papers/35899273PubMed
35696431Scaling up target regimens for tuberculosis preventive treatment in Brazil and South Africa: An analysis of costs and cost-effectiveness.PLoS Med2022https://conductscience.org/library/papers/35696431PubMed
35231047Mixed methods systematic review and metasummary about barriers and facilitators for the implementation of cotrimoxazole and isoniazid-Preventive therapies for people living with HIV.PLoS One2022https://conductscience.org/library/papers/35231047PubMed
33995803Facility and patient barriers in the implementation of isoniazid preventive therapy for people living with HIV attending Care and Treatment Centers, Songea Municipality, Tanzania.Pan Afr Med J2021https://conductscience.org/library/papers/33995803PubMed
33264300Outcomes of isoniazid preventive therapy among people living with HIV in Kenya: A retrospective study of routine health care data.PLoS One2020https://conductscience.org/library/papers/33264300PubMed
32773999Implementation of Isoniazid Preventive Therapy among People Living with HIV in Northwestern Nigeria: Completion Rate and Predictive Factors.J Glob Infect Dis2020https://conductscience.org/library/papers/32773999PubMed
32664847Factors affecting uptake and completion of isoniazid preventive therapy among HIV-infected children at a national referral hospital, Kenya: a mixed quantitative and qualitative study.BMC Infect Dis2020https://conductscience.org/library/papers/32664847PubMed
32460788A prospective cohort study of outcomes for isoniazid prevention therapy: a nested study from a national QI collaborative in Uganda.AIDS Res Ther2020https://conductscience.org/library/papers/32460788PubMed
32276618
Determinants of isoniazid preventive therapy completion among people living with HIV attending care and treatment clinics from 2013 to 2017 in Dar es Salaam Region, Tanzania. A cross-sectional analytical study.
BMC Infect Dis2020https://conductscience.org/library/papers/32276618PubMed
32180867Improving coverage and completion rate of isoniazid preventive therapy among eligible HIV patients using quality improvement approaches: a case study of State Hospital, Ijebu Ode, Ogun State, Nigeria.Pan Afr Med J2019https://conductscience.org/library/papers/32180867PubMed
32049259Access and adherence to isoniazid preventive therapy and occurrence of active TB in a cohort of people living with HIV: a retrospective cohort study in Sao Paulo, Brazil.Rev Inst Med Trop Sao Paulo2020https://conductscience.org/library/papers/32049259PubMed
31664978Inequality in uptake of isoniazid prevention therapy and Mantoux test among pregnant women with HIV in the Eastern Cape, South Africa.BMC Public Health2019https://conductscience.org/library/papers/31664978PubMed
31634189CD4+ cell count stratification to guide tuberculosis preventive therapy for people living with HIV.AIDS2020https://conductscience.org/library/papers/31634189PubMed
30758779Tolerability of Isoniazid Preventive Therapy in an HIV-Infected Cohort of Paediatric and Adolescent Patients on Antiretroviral Therapy from a Resource-Limited Setting: A Retrospective Cohort Study.Drugs Real World Outcomes2019https://conductscience.org/library/papers/30758779PubMed
30174886Effects of preventive therapy for latent tuberculosis infection and factors associated with treatment abandonment: a cross-sectional study.J Thorac Dis2018https://conductscience.org/library/papers/30174886PubMed

See all 38 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
HPD3242PubTator's text mininghttps://conductscience.org/library/genes/3242NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21079428

GET https://conductscience.org/api/papers/v1/21079428/cited_by?page=2